selected publications
-
academic article
-
Multiple myeloma treatment in real-world clinical practice: results of a prospective, multinational, non-interventional study.
Clinical Lymphoma Myeloma & Leukemia.
18.
2018
Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study.
Blood Advances.
2.
2018
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
PLoS ONE.
12.
2017
The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population‐based study.
Cancer Medicine.
6.
2017
Danish National Lymphoma Registry.
Clinical Epidemiology.
Volume 8.
2016
Smoldering multiple myeloma risk factors for progression: a Danish population‐based cohort study.
European Journal Of Haematology.
97.
2016
The Danish National Acute Leukemia Registry.
Clinical Epidemiology.
Volume 8.
2016
The Danish National Chronic Lymphocytic Leukemia Registry.
Clinical Epidemiology.
Volume 8.
2016
The Danish National Multiple Myeloma Registry.
Clinical Epidemiology.
Volume 8.
2016
A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry.
Leukemia & Lymphoma.
56.
2015
A population‐based study of prognosis in advanced stage follicular lymphoma managed by watch and wait.
British Journal of Haematology.
169.
2015
Analysis of Final Data from the Multinational, Non-Interventional, Observational Emmos Study (NCT01241396) in Patients (Pts) with Multiple Myeloma (MM) in Real-World Clinical Practice.
Blood.
126.
2015
Causes of early death in multiple myeloma patients who are ineligible for high‐dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database.
American Journal of Hematology.
90.
2015
Continued improvement in overall survival in elderly multiple myeloma patients after 2008; a population based study from the Danish Multiple Myeloma Registry.
Clinical Lymphoma Myeloma & Leukemia.
15.
2015
Frontline therapy for multiple myeloma (MM) in real-world clinical practice: Results from the third interim analysis of the multinational, non-interventional, observational EMMOS study.
Clinical Lymphoma Myeloma & Leukemia.
15.
2015
Outcome of treatment for first versus later relapse in multiple myeloma (MM) in real-world clinical practice: Results from the third interim analysis of the multinational, non-interventional, observational EMMOS study.
Clinical Lymphoma Myeloma & Leukemia.
15.
2015
Renal effects of NO‐inhibition in patients with cirrhosis vs. healthy controls: a randomized placebo‐controlled crossover study.
Liver International.
34.
2014
-
dataset
-
Baseline characteristics for the entire cohort..
public-library-of-science.
2017
Immunoparesis and association to OS and PFS in different age groups..
public-library-of-science.
2017
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
public-library-of-science.
2017
Multivariable analysis of both qualitative and quantitative immunoparesis as risk factors for OS and PFS in all patients..
public-library-of-science.
2017
Multivariable analysis of factors for OS..
public-library-of-science.
2017
Multivariable analysis of factors for PFS..
public-library-of-science.
2017